Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2000
10/19/2000WO2000024437A3 Textured and porous silicone rubber
10/19/2000WO2000007996A8 Pyrazoles as estrogen receptor modulators
10/19/2000DE19917930A1 Treating estrogen deficiency associated disorders, e.g. menopausal problems, osteoporosis, neoplasia or neurodegenerative disease, using new or known ent-steroids having bone-selective estrogenic activity
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2369262A1 Pulmonary administration of dry powder formulations for treating infertility
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/18/2000EP1044683A1 One-step dispersion method for the microencapsulation of water soluble substances
10/18/2000EP1044211A1 36 human secreted proteins
10/18/2000EP1044024A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site
10/18/2000EP1043993A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents
10/18/2000CN1057531C Androstanes steroids and their medicinal compositions and uses thereof
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133295 Pharmaceutical composition
10/17/2000US6133293 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action; potent depressive effect on diabetic hyperglycemia; 2,4-thiazolidinediones and oxazolidinediones
10/17/2000US6133288 2,8-di(hydroxy)-5-((2-piperidin-1-yl)ethyoxy-1,4-phenylene)-)-5h -benzo-(e)naphtho(1,2-c)pyran; post-menopausal syndrome, osteoporosis, cardiovascular disorders; uterine fibrosis, endometriosis, and aortal smooth muscle cell proliferation
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6132774 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
10/17/2000US6132760 Contains a therapeutically effective amount of testosterone and a delivery enhancing adjuvant comprising a terpene.
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000059946A1 Hydroxymatairesinol in cancer prevention
10/12/2000WO2000059920A2 Orally active 7.alpha.-alkyl androgens
10/12/2000WO2000059897A2 Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds
10/12/2000WO2000059577A1 Low dose estrogen interrupted hormone replacement therapy
10/12/2000WO2000059512A1 Formulation comprising testosteron undecanoate and castor oil
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059482A1 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
10/12/2000WO2000023594A9 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2303702A1 Growth hormone and growth hormone releasing hormone compositions
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042468A2 Low-voltage activated calcium channel compositions and methods
10/11/2000EP1042355A1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments
10/11/2000EP1042352A1 Androgenic steroid compounds and a method of making and using the same
10/11/2000EP1042325A1 Nitrogen-containing heterocyclic compounds, their production and use
10/11/2000CN1269834A Expression of gonadotropins in i (dictyostelium)
10/11/2000CN1269716A Transdermal therapeutic system (TTS) for administrating sexual steroid hormones
10/11/2000CN1057305C Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceuticals
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058360A2 Analogs of gastric inhibitory peptide and their use for treatment of diabetes
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058348A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058337A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
10/05/2000WO2000058279A1 Diaryl derivatives and their use as medicaments
10/05/2000WO2000058276A1 7-amino-4-hydroxy-3-(4-methoxy-phenylazo)-naphthalene-2-sulfonic acid derivatives as fsh antagonists
10/05/2000WO2000057864A2 Cyclic glycerophosphates and analogs thereof
10/05/2000WO2000057853A2 Pharmaceutical composition containing an extrusion additive
10/05/2000WO2000032178A3 Use of siburamine for the treatment of disorders of the central nervous system secondary to organic impairments
10/05/2000WO2000030624A3 Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000DE19916383A1 Pharmazeutische Zusammensetzung mit einem Extrusionsstoff A pharmaceutical composition comprising an extrusion material
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2367882A1 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
10/05/2000CA2367856A1 Analogs of gastric inhibitory peptide and their use for treatment of diabetes
10/05/2000CA2367792A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
10/05/2000CA2365995A1 Cyclic glycerophosphates and analogs thereof
10/05/2000CA2361016A1 Diaryl derivatives and their use as medicaments
10/04/2000EP1041071A1 Methods for the preparation of coumarine derivatives
10/04/2000EP1041066A1 Steroid receptor modulator compounds and methods
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000CN1268375A Application of hypermnesia peptide in preparation of medicine for curing menopausal syndrome
10/04/2000CN1056997C Application of theaflavine for prepn. of medicine for lowering endotheliotoxin
10/04/2000CN1056985C Health-care traditional Chinese medicine Massa Medicate fermentata oral liquor and its prepn. method
10/03/2000US6127519 Calcitonin derivatives
10/03/2000US6127414 Antagonists of neuropeptide y and, in particular, in the treatment of cardiovascular diseases, e.g., vasoconstriction; hypotensive agents
10/03/2000US6127404 Tissue selective compounds in the treatment of endometrial proliferation
10/03/2000US6127391 Compounds with growth hormone releasing properties
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127354 For treatment of growth disorders or to stimulate production of wool or milk
09/2000
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056883A1 49 human secreted proteins
09/28/2000WO2000056864A2 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1)
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056739A1 Thienopyrimidine compounds, their production and use
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056297A2 Pharmaceutical compositions comprising dipeptidy peptidase iv inhibitors for the promotion of growth
09/28/2000WO2000033839B1 Non-peptide antagonists of glp-1 receptor and methods of use
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000DE19911771A1 Neue LHRH-Antagonisten mit verbesserten Löslichkeitseigenschaften New LHRH antagonists with improved solubility
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2512479A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000CA2512291A1 Pro4356 polypeptides and nucleic acids encoding the same
09/28/2000CA2510982A1 Lectin-like protein, pro1890, encoding nucleic acids, pro1890 antibodies and uses thereof
09/28/2000CA2510931A1 Pro4334 polypeptides and nucleic acids
09/28/2000CA2510806A1 Screted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 290